المؤلفون: Haruo Fujikane, Hidetoshi Kamimura, Satoshi Kawata, Susumu Kaneshige, Tadahiro Ikeuchi, Yuki Otsu, 兼重 晋, 大津 友紀, 川田 哲史, 池内 忠宏, 神村 英利, 藤金 治雄

المصدر: Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics. 2021, :2-7

المؤلفون: Atsushi Washiyama, Hiroaki Inokuchi, Koujiro Futagami, Tomoka Yamamoto, Syouichi Siotuka, Haruo Fujikane, Yoshihiro Kawahara, Tadahiro Ikeuti

المصدر: Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35:752-761

مصطلحات موضوعية: Medical education, Psychology, Training (civil), Term (time)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1ae0e1fd0d6b92540c94dfe697e69c65
https://doi.org/10.5649/jjphcs.35.752

المؤلفون: Yuji Yoshiyama, Koichiro Atsuda, Katsuya Otori, Kentaro Ogata, Haruo Fujikane, Kazuo Yago, Koujiro Futagami

المصدر: Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33:365-369

مصطلحات موضوعية: Chemistry, media_common.quotation_subject, Stability (probability), humanities, Generic drug, Product (mathematics), Elcatonin, medicine, Quality (business), sense organs, skin and connective tissue diseases, Biological system, media_common, Light exposure, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0d0b189c7a0d3a900d9c5bb7183b84db
https://doi.org/10.5649/jjphcs.33.365

المؤلفون: Koujiro Futagami, Junji Suzumiya, Yasushi Takamatsu, Shuuji Hara, Masanobu Uchiyama, Kazuo Tamura, Haruo Fujikane, Kentaro Ogata

المصدر: Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33:50-53

مصطلحات موضوعية: Imatinib mesilate, business.industry, medicine.medical_treatment, Immunology, medicine, Myeloid leukemia, medicine.symptom, Liver dysfunction, business, Rash, Desensitization therapy, Desensitization (medicine)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b11de6393c264ec74fffbd09b1dc8264
https://doi.org/10.5649/jjphcs.33.50

المؤلفون: Haruo Fujikane, Kentaro Ogata, Yasushi Takamatsu, Mana Fujita, Kenji Ishitsuka, Masanobu Uchiyama, Naoko Kunami, Kazuo Tamura, Tomona Toyota, Hiroo Katsuya, Masanao Ishizu, Shuuji Hara, Hidenori Sasaki

المصدر: International Journal of Hematology. 92:762-764

مصطلحات موضوعية: Male, Combination therapy, viruses, Antineoplastic Agents, Pilot Projects, Disease, Adult T-cell leukemia/lymphoma, Zidovudine, Japan, Refractory, Recurrence, immune system diseases, hemic and lymphatic diseases, Interferon α, parasitic diseases, Humans, Leukemia-Lymphoma, Adult T-Cell, Medicine, business.industry, Interferon-alpha, Endemic area, Receptors, Interleukin-2, hemic and immune systems, Hematology, Middle Aged, medicine.disease, Treatment Outcome, Immunology, Relapsed refractory, Drug Therapy, Combination, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8d7ba4ed9e03081f90b3ad09bc538db
https://doi.org/10.1007/s12185-010-0717-3